View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Central Nervous System Stimulant

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Data on pharmaceuticals reported by H.M. Marston and co-researchers

2009 NOV 23 ... Antidyskinetic, Antiparkinson, Antipsychotic, Apomorphine, Bipolar Disorder, Central Nervous System Stimulant, Dopamine, Dopamine Agonist, Drugs, Manic-Depressive Illness, Mental Health, Neurology, ...

Subject: Pharmaceuticals

Price: $3.00

Local health investigation sheds light on gastroschisis birth defect

2009 NOV 28 ... Adrenergic Uptake Inhibitor, Amphetamine, Bronchodilator, Central Nervous System Agent, Central Nervous System Stimulant, Clinical Trial Research, Cocaine, Community Health, Dopamine, Epidemiology, ...

Subject: University of Nevada, Reno

Price: $3.00

New DNA research study results from Shanghai Institute of Materia Medica, Research Division described

2009 NOV 23 ... Anticancer Therapy, Ataxia Telangiectasia, Biotechnology, Caffeine, Cancer Gene Therapy, Central Nervous System Stimulant, Colon Cancer, Colon Carcinoma, DNA Damage, DNA Research, Deoxyribonucleic Acid, ...

Subject: DNA Research

Price: $3.00

New findings in life sciences described from Merck & Company, Inc.

2009 NOV 23 ... Pharmaceutical Company, Amphetamine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Central Nervous System Stimulant, Dopamine, Olanzapine, Pharmaceuticals, Drugs, Therapy, Treatment, Dopamine ...

Subject: Life Sciences

View Free
Daily News
Article

New pharmaceuticals study results from University of North Carolina, Medical Department described

2009 NOV 16 ... Chapel Hill, Anorexigenic Agent, Antidyskinetic, Antiparkinson, Cabergoline, Cardiology, Central Nervous System Agent, Dopamine Agonist, Drug Development, Drugs, FDA, Fenfluramine, ... Pharmacology, Regulatory Actions, Serotonin Antagonist, Serotonin Reuptake Inhibitor, Stimulant, Sympatholytic, Therapy, Treatment, U.S. Food and Drug Administration, Valvular Heart ...

Subject: Pharmaceuticals

Price: $3.00

Real-World Patient Experiences on Medications for Chronic Conditions: Innovative InfoMedics Studies Presented at Three Medical Conferences in October

2009 NOV 16 ... Treatment, Ulcer, Ulcerative Colitis. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... lisdexamfetamine dimesylate (LDX; Vyvanse®, Shire US Inc.), a long-acting prodrug stimulant indicated for attention-deficit/hyperactivity disorder (ADHD). Two of the studies ...

Subject: Pediatrics

Price: $3.00

Report summarizes schizophrenia study findings from Tel-Aviv University

2009 NOV 23 ... Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Antipsychotic, Central Nervous System Stimulant, Clozapine, Dopamine, Drugs, Endocrinology, Estradiol, Estrogen, Haloperidol, Hormones, ...

Subject: Schizophrenia

Price: $3.00

Reports from M.B. Haffey et al highlight recent research in pharmacokinetics

2009 NOV 23 ... Inhibitor, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Amphetamine, Central Nervous System Stimulant, Dopamine, Drugs, Lisdexamfetamine Dimesylate, Omeprazole, Pharmaceuticals, ...

Subject: Pharmacokinetics

Price: $3.00

Reports from W. Adams and colleagues advance knowledge in schizophrenia

2009 NOV 23 ... Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Analgesic, Anesthetic, Central Nervous System Stimulant, Cocaine, Dopamine, Ketamine, Pharmaceuticals, Psychiatry, Psychopharmacology, ...

Subject: Schizophrenia

Price: $3.00

Research from C. Forlini and co-authors yields new data on bioethics

2009 NOV 16 ... Keywords: Canada, Montreal, Adrenergic Agent, Adrenergic Uptake Inhibitor, Bioethics, Central Nervous System Stimulant, Dopamine Uptake Inhib, Drugs, Methylphenidate, Methylphenidate Hydrochloride, ...

Subject: Bioethics

Price: $3.00

Research from University of Utrecht yields new findings on psychopharmacology

2009 NOV 28 ... Life Sciences, Amphetamine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Central Nervous System Stimulant, Dopamine, Haloperidol, Pharmaceuticals, Drugs, Therapy, Treatment, Risperidone, ...

Subject: Psychopharmacology

Price: $3.00

Research in the area of schizophrenia therapy reported from Polish Academy of Sciences, Pharmacology Department

2009 NOV 23 ... Agent, Adrenergic Uptake Inhibitor, Amphetamine, Antipsychotic, Behavior, Biochemical, Central Nervous System Stimulant, Cocaine, Dopamine, Dopamine Hydrochloride, Drugs, Mental Health, Metabolism, Neurology, ...

Subject: Schizophrenia Therapy

Price: $3.00

Research reports from Keio University, Medical Department provide new insights into parkinsonian disorders

2009 NOV 16 ... Inhibitor, Amphetamine, Behavior, Bioengineering, Biomedical Engineering, Biomedicine, Central Nervous System Stimulant, Dopamine, Neural Transplantation, Neurosurgery, Parkinsonian Disorders, Physiology, ...

Subject: Parkinsonian Disorders

Price: $3.00

Research results from Michigan State University update knowledge of proteomics

2009 NOV 23 ... Country:United States, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Central Nervous System Stimulant, Cocaine, Dopamine, Drugs, Estradiol, Hormones, Peptide, Pharmaceuticals, Proteins, ...

Subject: Proteomics

Price: $3.00

Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD

2009 NOV 16 ... Bipolar Disorder, Central Nervous System Disease, Central Nervous System Infection, Central Nervous System Stimulant, Central Nervous System Tumors, Clinical Trial Research, Daytrana, Depression, ...

Subject: Tics

Price: $3.00

Study results from Harvard University provide new insights into pharmaceuticals

2009 NOV 16 ... Belmont, Addiction Medicine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Central Nervous System Stimulant, Cocaine, Dopamine, Dopamine Hydrochloride, Drugs, Experimental Therapies, Mental ...

Subject: Pharmaceuticals

Price: $3.00

Study results from Northumbria University provide new insights into hypoglycemia

2009 NOV 16 ... United Kingdom, Alternative Medicine, Anorexigenic Agent, Applied Physiology, Caffeine, Central Nervous System Stimulant, Hypoglycemia, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Northumbria ...

Subject: Hypoglycemia

Price: $3.00

Teeth Grinding Linked to Sleep Apnea

2009 NOV 16 ... Keywords: Acid Reflux, Anorexigenic Agent, Anxiety Disorder, Bruxism, Caffeine, Central Nervous System Stimulant, Craniofacial, Gastroesophageal Reflux, Gastrointestinal Reflux Disease, Obstructive ...

Subject: Gastrointestinal Reflux Disease

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx